Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA). It operates through four segments: New Zealand, North America, Europe, and Asia-Pacific. The company offers adult respiratory products, such as AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, including resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers surgical humidification systems; and homecare products comprising masks, CPAP devices, data management, humidifiers, and accessories. It markets and sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone64 9 574 0100
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees4,000
Next Earnings DateN/A
OptionableNot Optionable
Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Frequently Asked Questions
What is Fisher & Paykel Healthcare's stock symbol?
Fisher & Paykel Healthcare trades on the OTCMKTS under the ticker symbol "FSPKF."
What is the consensus analysts' recommendation for Fisher & Paykel Healthcare?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fisher & Paykel Healthcare in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Fisher & Paykel Healthcare.
Has Fisher & Paykel Healthcare been receiving favorable news coverage?
News coverage about FSPKF stock has trended somewhat negative this week, InfoTrie reports. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Fisher & Paykel Healthcare earned a news sentiment score of -1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Fisher & Paykel Healthcare.
Who are some of Fisher & Paykel Healthcare's key competitors?
What other stocks do shareholders of Fisher & Paykel Healthcare own?
Who are Fisher & Paykel Healthcare's key executives?
Fisher & Paykel Healthcare's management team includes the folowing people:
- Mr. Lewis G. Gradon, MD, CEO & Exec. Director (Age 58)
- Ms. Andrea Blackie, Acting Chief Financial Officer
- Dr. Andrew Somervell, VP of Products & Technology
- Rachel Reynolds, Sr. Communications Mang.
- Mr. Paul N. Shearer, Sr. VP of Sales & Marketing
How do I buy shares of Fisher & Paykel Healthcare?
Shares of FSPKF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Fisher & Paykel Healthcare's stock price today?
One share of FSPKF stock can currently be purchased for approximately $13.07.
What is Fisher & Paykel Healthcare's official website?
How can I contact Fisher & Paykel Healthcare?
The company can be reached via phone at 64 9 574 0100.
MarketBeat Community Rating for Fisher & Paykel Healthcare (OTCMKTS FSPKF)
MarketBeat's community ratings are surveys of what our community members think about Fisher & Paykel Healthcare and other stocks. Vote "Outperform" if you believe FSPKF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FSPKF will underperform the S&P 500 over the long term. You may vote once every thirty days.
